LABETALOL HYDROCHLORIDE — all Canadian products
22 DINs
15 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is LABETALOL HYDROCHLORIDE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02243538 | APO-LABETALOL | APOTEX INC | Tablet | Oral | LABETALOL HYDROCHLORIDE 100 MG | Marketed | |
| 02243539 | APO-LABETALOL | APOTEX INC | Tablet | Oral | LABETALOL HYDROCHLORIDE 200 MG | Marketed | |
| 02457040 | LABETALOL HYDROCHLORIDE INJECTION | OMEGA LABORATORIES LIMITED | Solution | Intravenous | LABETALOL HYDROCHLORIDE 5 MG | Marketed | |
| 02557037 | LABETALOL HYDROCHLORIDE INJECTION IN 0.72% SODIUM CHLORIDE | HIKMA CANADA LIMITED | Solution | Intravenous | LABETALOL HYDROCHLORIDE 1 MG | Approved | |
| 02557029 | LABETALOL HYDROCHLORIDE INJECTION IN 5% DEXTROSE | HIKMA CANADA LIMITED | Solution | Intravenous | LABETALOL HYDROCHLORIDE 1 MG | Approved | |
| 02541505 | LABETALOL HYDROCHLORIDE INJECTION USP | JAMP PHARMA CORPORATION | Solution | Intravenous | LABETALOL HYDROCHLORIDE 5 MG | Marketed | |
| 02385120 | LABETALOL HYDROCHLORIDE INJECTION USP | STERIMAX INC | Solution | Intravenous | LABETALOL HYDROCHLORIDE 5 MG | Marketed | |
| 02231689 | LABETALOL HYDROCHLORIDE INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | Intravenous | LABETALOL HYDROCHLORIDE 5 MG | Marketed | |
| 02340194 | LABETALOL HYDROCHLORIDE INJECTION, USP | STRIDES PHARMA CANADA INC | Solution | Intravenous | LABETALOL HYDROCHLORIDE 5 MG | Approved | |
| 02503255 | MINT-LABETALOL | MINT PHARMACEUTICALS INC | Tablet | Oral | LABETALOL HYDROCHLORIDE 100 MG | Approved | |
| 02503263 | MINT-LABETALOL | MINT PHARMACEUTICALS INC | Tablet | Oral | LABETALOL HYDROCHLORIDE 200 MG | Approved | |
| 02489406 | RIVA-LABETALOL | LABORATOIRE RIVA INC. | Tablet | Oral | LABETALOL HYDROCHLORIDE 100 MG | Marketed | |
| 02489414 | RIVA-LABETALOL | LABORATOIRE RIVA INC. | Tablet | Oral | LABETALOL HYDROCHLORIDE 200 MG | Marketed | |
| 02106272 | TRANDATE | KNIGHT THERAPEUTICS INC. | Tablet | Oral | LABETALOL HYDROCHLORIDE 100 MG | Marketed | |
| 02106280 | TRANDATE | KNIGHT THERAPEUTICS INC. | Tablet | Oral | LABETALOL HYDROCHLORIDE 200 MG | Marketed | |
| 02539101 | LABETALOL HYDROCHLORIDE INJECTION | JUNO PHARMACEUTICALS CORP. | Solution | Intravenous | LABETALOL HYDROCHLORIDE 5 MG | Cancelled Pre Market | |
| 02391090 | LABETALOL HYDROCHLORIDE INJECTION USP | PFIZER CANADA ULC | Solution | Intravenous | LABETALOL HYDROCHLORIDE 5 MG | Cancelled Post Market | |
| 02387468 | LABETALOL HYDROCHLORIDE INJECTION, USP | MYLAN PHARMACEUTICALS ULC | Solution | Intravenous | LABETALOL HYDROCHLORIDE 5 MG | Cancelled Post Market | |
| 02091518 | TRANDATE 5MG/ML | SHIRE BIOCHEM INC | Liquid | Intravenous | LABETALOL HYDROCHLORIDE 5 MG | Cancelled Post Market | |
| 01924923 | TRANDATE INJ 5MG/ML | GLAXO CANADA INC | Liquid | Intravenous | LABETALOL HYDROCHLORIDE 5 MG | Cancelled Post Market | |
| 01924915 | TRANDATE TAB 100MG | GLAXO CANADA INC | Tablet | Oral | LABETALOL HYDROCHLORIDE 100 MG | Cancelled Post Market | |
| 01924931 | TRANDATE TAB 200MG | GLAXO CANADA INC | Tablet | Oral | LABETALOL HYDROCHLORIDE 200 MG | Cancelled Post Market |
Browse other molecules: